Literature DB >> 6711513

The kind of plaque that underlies a coronary thrombus.

R E Tracy.   

Abstract

The life span of the human species is about 70 years. The evolutionary strategy used by the species to attain this unusually long life span was not to avoid all coronary plaque formation, but rather to live a long time with coronary plaques in place. Only a rare kind of coronary plaque is thrombogenic and, therefore, fatal in young people. In a forensic service, the author has repeatedly encountered cases of sudden death in men under age 40 wherein a tiny, pale nonocclusive thrombus over a focal plaque was determined to be the cause of death. The histology of these plaques was consistently different from the commonplace innocuous plaques in older subjects. The thrombogenic plaque was marked by the triad: 1) cell-rich, bulky fibrous cap and base accompanying atheronecrosis, 2) phagocytosis in the necrosis-base boundary, and 3) adventitial inflammation. Atheronecrotic bases were commonplace in most innocuous plaques as well as universal in thrombogenic ones. These matters have not been subjected to systematic objective confirmation, and are offered here as hypotheses.

Entities:  

Mesh:

Year:  1984        PMID: 6711513     DOI: 10.1097/00000433-198403000-00004

Source DB:  PubMed          Journal:  Am J Forensic Med Pathol        ISSN: 0195-7910            Impact factor:   0.921


  3 in total

1.  Evidence for toxic anthropogenic chemicals in human thrombogenic coronary plaques.

Authors:  J B Ferrario; I R DeLeon; R E Tracy
Journal:  Arch Environ Contam Toxicol       Date:  1985-09       Impact factor: 2.804

2.  Characteristics of the plaque under a coronary thrombus.

Authors:  R E Tracy; K Devaney; G Kissling
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

3.  Chronic miR-29 antagonism promotes favorable plaque remodeling in atherosclerotic mice.

Authors:  Victoria Ulrich; Noemi Rotllan; Elisa Araldi; Amelia Luciano; Philipp Skroblin; Mélanie Abonnenc; Paola Perrotta; Xiaoke Yin; Ashley Bauer; Kristen L Leslie; Pei Zhang; Binod Aryal; Rusty L Montgomery; Thomas Thum; Kathleen Martin; Yajaira Suarez; Manuel Mayr; Carlos Fernandez-Hernando; William C Sessa
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.